Associated Papers
Case report: A rare DLST mutation in patient with metastatic pheochromocytoma: clinical implications and management challenges.
Li C et al.
Frontiers in Oncology, 2024
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling.
Mellid S et al.
Cancer Communications (london, England), 2023
Over-Mutated Mitochondrial, Lysosomal and TFEB-Regulated Genes in Parkinson's Disease.
Segur-Bailach E et al.
Journal of Clinical Medicine, 2022
35330074 (PubMed )
Supplement: jcm-11-01749-s001.zip › Supl_Table_S2.pdf
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma.
Mellid S et al.
Frontiers in Endocrinology, 2022
Germline DLST Variants Promote Epigenetic Modifications in Pheochromocytoma-Paraganglioma.
Buffet A et al.
The Journal of Clinical Endocrinology and Metabolism, 2021
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Remacha L et al.
American Journal of Human Genetics, 2019
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Remacha L et al.
American Journal of Human Genetics, 2019
Select a paper to view details